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Is Pemphigus Vulgaris Antigen an Intercellular Cement? 
It is established that in pemphigus vulgaris, autoantibodies cause 
loss of keratinocyte cell-to-cell adhesion. Because of this loss of 
adhesion, it has been assumed that the pemphigus vulgaris antigen 
(PV A) defined by these autoantibodies functions as an adhesive 
molecule. Along these lines, pemphigus vulgaris antibodies are 
sometimes said to bind to "intercellular cement substance." eDNA 
cloning demonstrating that PYA is in the supergene family of cad-
herin homophilic cell adhesion molecules, and recent immunoelec-
tron microscopic localization of PV A to desmosomes, cell adhesion 
junctions, also support the concept that PYA might function in 
adhesion. 
In this issue, Amagai et al (p. 402) directly tested the hypothesis 
that the extracellular domain of PV A expressed on the cell surface 
can function in homophilic cell-cell adhesion. If L cells, mouse 
fibroblasts that do not normally aggregate with each other, are 
induced to express E-cadherin on their surface by transfection of 
E-cadherin eDNA, they acquire the ability to aggregate. Studies 
such as these have demonstrated that E-cadherin, one of th'e origi-
nally described members of the cadherin supergene family, could be 
considered a cell cement. In this issue, Amagai et al simply replaced 
the extracellular domain of E-cadherin with that of PYA by trans-
fecting these cells with a chimeric eDNA. The authors were sur-
prised to find that although transfected clones expressed PYA on the 
cell surface, these cells aggregated only very weakly compared to 
cells expressing E-cadherin. The significance of these findings is 
that we cannot simply consider the extracellular domain ofpVA as a 
"cement substance." Either PYA does not function as a strong adhe-
sion molecule. or other factors such as the PYA cytoplasmic domain 
(missing in the chimeric construct) or other desmosomal compo-
nents ar-e necessary for optimal adhesive function. Implications for 
future studies are that PV A adhesive function should be tested with 
additiol"lal components. Finally, other potential functions of PYA, 
such as signal transduction, should be considered. 
What Controls the Ordered Differentiation of the Epidermis? 
Differentiation in the epidermis is characterized by the ordered 
expression of specific proteins that appear sequentially as keratino-
cytes migrate from the basal layer to the stratum corneum, but the 
biochemical pathways controlling this process are poorly defined. 
In cultured keratinocytes, increases in the concentration of extracel-
lular Ca++ can trigger expression of keratinocyte differentiation 
markers and, in skin, a Ca++ gradient has been found. These find-
ings suggest that Ca++ may regulate epidermal differentiation ill 
vivo. 
Earlier studies using 12-0-tetradecanoylphorbol-13-acetate 
(TP A), an activator of protein kinase C (PKC), have also implicated 
the PKC signaling pathway as a regulator of keratinocyte differen-
tiation. TPA can substitute for extracellular Ca++ to induce trans-
glutaminase activity and subsequent formation of cross-linked cor-
nified cell envelopes characteristic of terminally differentiated 
squames. Because Ca++-mediated keratinocyte differentiation is 
associated with accumulation of the endogenous PKC activator, 
diacylglycerol, Ca++ may stimulate normal keratinocyte differen-
tiation by activating the PKC pathway. 
In this issue, Dtugosz and Yuspa (p. 409) test this idea by examin-
ing the regulation of the keratinocyte transglumaminase (TGJ 
gene in eLlltured epidermal keratinocytes. Both Ca++ and TPA in-
creased "TGk gene transcription, and this response was blocked by 
inhibitill.g PKC. The results strongly suggest that Ca++-induced 
expressicm of the TGk gene is mediated by the PKC signaling path-
way, providing additional support for the concept that PKC plays a 
pivotal role in regulating late stages of epidermal differentiation (see 
also J Cell Bioi 120:217 -225, 1993). Because increased expression 
of TGk naS been demonstrated in psoriasis U [rlvest DermatoI99:27-
34, 199~), PKC inhibitors may be useful in treating psoriasis and 
possibly other hyperkeratotic skin disorders. 
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Gene Transfer and the Skin 
The excitement of gene therapy as a therapeutic strategy lies in the 
potential of delivering in villo in humans any of the hundreds of 
thousands of genes in the human genome as therapeutic agents. In 
this issue, Setoguchi and colleagues (p. 415) demonstrate that aden-
oviruses modified to be replication deficient and containing a po-
tentially therapeutic gene can be injected directly into the skin, and 
that the exogenous gene is expressed and the encoded protein is 
produced in the skin. As a model for the concept of delivering genes 
to the skin the investigators utilized a marker gene (p-galactosidase) 
and the human secreted protein aI-antitrypsin. The study demon-
strates clearly that genes can be transferred to the skin of rodents and 
that the human a-antitrypsin gene transferred in the adenovirus 
vector is secreted, because human a-antitrypsin, from the trans-
ferred gene, could be detected in the serum. The method may be 
applicable to a broad variety of hereditary and acquired disorders in 
which the transfer, expression, and secretion of an appropriate gene 
would be therapeutic. Equally important, the easy accessibility and 
the high vascu larity of the skin make for an ideal site for il1l1illO gene 
therapy in which proteins from the transferred genes are secreted 
into the systemic circulation. If this method is also shown to be 
effective in humans, it could become one of the accepted methods 
for human gene therapy. 
Some Targets of Ultraviolet Radiation May Be in the Cytoplasm Rather than in the Nucleus . .. 
Two studies in this issue examine the mechanism of UV effects in 
keratinocytes and show that multiple pathways may be involved. 
Over the last two decades, substantial progress has been 1l'lade in 
defining the cellular targets and mechanisms by which UV radia-
tion affects the skin immune system of rodents and humans . In 
addition to Langerhans cells, keratinocytes represent an important 
cellular target for ultraviolet B radiation (UVB) (290 - 315 nm). 
When UVB strikes a cell, it induces several events including release 
of cytokines, alteration of proliferation, and expression of surface 
markers. Any external signal affecting a cell needs a recepto.r that 
transmits the stimulus. Because damaging effects of UVB can be 
prevented by inducing DNA repair, DNA damage is thought to be a 
prerequisite, and it is generally accepted that DNA is the cellular 
target, a sort of receptor, for UVE. 
In this issue, Simon et al (p. 422), in experiments with an epider-
moid caTcinoma cell line, show that DNA is not the only target of 
UVB. First, they show that NFkB, a transcriptional activator found 
inactive in the cytoplasm complexed with an inhibitory protein 
IkB, can be activated by UVB. Second, they show that NFkB can be 
activated by UVE in the absence of nuclear DNA. If the UVB 
response requires DNA damage, then a nuclear signal would have to 
be transferred to the cytoplasm to induce dissociation of the 
NFkB: IkB complex. Simon et al found, however, that DNA-free 
cytosolic extracts exposed to UVB were able to activate NFkB, 
strongly suggesting that a nuclear signal is not required. 
After submission of this report to the JID, a paper by Devary et at 
from San Diego addressing a similar issue appeared in Sciel1ce (vol-
ume 261, p. 1442). The San Diego group, headed by Michael Karin, 
came to similar conclusions using lethal doses ofUVC, whereas the 
Munster team headed by Thomas Schwartz used sublethal doses of 
the biologically more relevant UVB. Although neither paper con-
tradicts the generally accepted view that DNA is an important cel-
lular target for UVE, these two studies demonstrating that DNA 
damage is not a prerequisite for some UV effects indicate that DNA 
is not the only target. 
. . . but DNA Damage is Required for Others 
UVB is known to modulate the capacity of keratinocytes both to 
produce soluble mediators, e.g., cytokines, and also to express the 
adhesion molecule intercellular adhesion molecule-l (ICAM-l) at 
the cell surface. Keratinocyte ICAM-l exrression is an important 
prerequisite for the physical interaction 0 keratinocytes with leu-
kocytes, and reduction ofICAM-l expression produced by UVB is 
therefore thought to have a major impact on the immune responses 
in the skin. Little is currently known about the photobiologic ef-
fects by which UVB modulates ICAM-l expression. 
In this issue, Krutmann and coworkers (p. 428) addressed this 
problem in an ill vitro model testing the ability of UVB to decrease 
ICAM-l expression. In this photoimmunologic model system, they 
used interferon-y to stimulate ICAM-l expression and then tested 
the e.ffect ofUVB on interferon-y- stimulated ICAM-l expression. 
Studies companng xeroderma pigmentosum cells (deficient in 
DNA excision repair) and normal cells revealed that UVB-induced 
DNA photoproducts are required for the ability ofUVB to inhibit 
the increase in ICAM-l expression normally produced by inter-
feron-y. Although DNA damage from UVB has been implicated 
preVIOusly 111 I11creased gene expression, this report indicates that 
the generation of DNA photoproducts of UVB may also cause 
suppreSSIOn of gene expression. The specific DNA photoproduct 
I11volved 111 tl1lS system is not known. These studies further empha-
SLze the relevance of DNA as a chromophore for UVB-induced 
immunodulation. 
